Authorized purpose: Myomics assists qualified medical professionals with viewing, post-processing and qualitative/quantitative evaluation of 3T cardiovascular MR images in DICOM format, including heart and adjacent-vessel measurements; semi-automated machine-learning workflows are intended for adults and contribute to comprehensive diagnostic decision-making.
Clinical role
Measurement, segmentation and quantification
Images and patients
MRI · Heart/Cardiovascular
Key limitation
Keep in mind: Use only cardiac MR images from 3.0 T scanners. Semi-automated ML is intended for adults. Qualified cardiovascular-MR professionals must use results within comprehensive diagnostic assessment.
Clinical detailsPurpose, workflow fit, evidence, and safety record
Workflow navigation pilot
Workflow role has not yet been reviewed for this navigation pilot.
A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources
What does this software do?Authorized purpose: Myomics assists qualified medical professionals with viewing, post-processing and qualitative/quantitative evaluation of 3T cardiovascular MR images in DICOM format, including heart and adjacent-vessel measurements; semi-automated machine-learning workflows are intended for adults and contribute to comprehensive diagnostic decision-making.
Which images or clinical context are in scope?Modality: MRI Anatomy or clinical context: Heart/Cardiovascular Input: DICOM cardiovascular MR images acquired at 3.0 T; AI modules cover native/post-contrast T1 maps, T2 maps, CINE, LGE PSIR, CINE RV and LGE magnitude.
Who uses it?Intended users: Qualified medical professionals experienced in examining and evaluating cardiovascular MR images
What does the software produce?Output: Semi-automatic endocardial/epicardial and myocardium segmentation across supported sequences, heart/adjacent-vessel measurements, image display, manual contouring and reports.
What is its most important limitation?Key limitation: Use only cardiac MR images from 3.0 T scanners. Semi-automated ML is intended for adults. Qualified cardiovascular-MR professionals must use results within comprehensive diagnostic assessment.
Clinical takeaway. Clinical role: Myomics assists qualified medical professionals with viewing, post-processing and qualitative/quantitative evaluation of 3T cardiovascular MR images in DICOM format, including heart and adjacent-vessel measurements; semi-automated machine-learning workflows are intended for adults and contribute to comprehensive diagnostic decision-making.
Evidence takeaway. Evidence from the reviewed source record: Exact FDA technical validation is available. Stored cardiac-MR publications require full version review before application to K241922; one unrelated myosin paper is excluded.
Evidence context
Evidence context not reviewed for this FDA record.
Public-label constraints
Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.
Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.
Purpose
Myomics assists qualified medical professionals with viewing, post-processing and qualitative/quantitative evaluation of 3T cardiovascular MR images in DICOM format, including heart and adjacent-vessel measurements; semi-automated machine-learning workflows are intended for adults and contribute to comprehensive diagnostic decision-making.
Hospital or private-practice cardiovascular MR analysis; manual workflows have no stated population restriction, while semi-automated ML workflows are adult-only.
Use only cardiac MR images from 3.0 T scanners. Semi-automated ML is intended for adults. Qualified cardiovascular-MR professionals must use results within comprehensive diagnostic assessment.
Exact FDA technical validation is available. Stored cardiac-MR publications require full version review before application to K241922; one unrelated myosin paper is excluded.
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
Evidence summary
Exact FDA technical validation is available. Stored cardiac-MR publications require full version review before application to K241922; one unrelated myosin paper is excluded.
Reviewed exact-submission evidence reports segmentation overlap, not a disease-detection sensitivity.
Reported specificity
Not established in reviewed sources
Reviewed sources checked
Exact FDA submission
Checked 2026-09-05
A disease-detection specificity for this release was not established in the reviewed sources.
No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.
K241922 Myomics bench and AI-module validation
DesignManufacturer bench comparison with Myomics Q/cvi42 Auto and held-out testing of seven segmentation modules
Population728 module-level anonymized test cases across MR vendors; module denominators 92, 91, 109, 90, 77, 192 and 77
Scopeexact submission
Tested versionMyomics configuration submitted in K241922; numerical release unspecified
Samplen=728
IndependenceSponsor or vendor study
K241922
Sample size is the summed module-case count, not confirmed unique patients. All modules reportedly exceeded mean Dice 0.7; detailed estimates, confidence intervals and reference-annotation methods were not established.
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
Postmarket safety review
Not established in reviewed sources
Reviewed sources checked
Exact FDA submission
Checked 2026-09-04
No native submission-identifier match was found in the checked openFDA radiology recall snapshot. Product-name, manufacturer, and adverse-event searches remain necessary; this does not establish that no recall or safety report exists.
Pricing & contractsPublic price, contract terms, and reimbursement
IT implementationDeployment, interfaces, data handling, and support
System and version relationships
Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.
No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.
Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.
Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner
No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.
Acquisition/source
Source context, not route validation: DICOM cardiovascular MR images acquired at 3.0 T; AI modules cover native/post-contrast T1 maps, T2 maps, CINE, LGE PSIR, CINE RV and LGE magnitude.
Scope: Exact FDA submission.
Confirm scanner/model, protocol, series completeness and both software builds.
Source context, not route validation: Stand-alone software application with a graphical interface, described for integration into hospital or private-practice environments.
Scope: Exact FDA submission. The summary does not establish current hosting architecture, compute sizing, region or latency.
Confirm processing location, queue ownership, exclusions and exact AI build.
Unresolved route: Semi-automatic endocardial/epicardial and myocardium segmentation across supported sequences, heart/adjacent-vessel measurements, image display, manual contouring and reports.
Scope: Exact FDA submission.
Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.
Unresolved route: Not established for the exact route.
Scope: Scope not established.
Name the local, platform and AI supplier support owners and escalation path.
Planned local route tests
No tests below have been performed or accepted.
Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.
Local implementation checklist
Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.
Phantomics identifies Myomics as its cardiac MRI analysis solution and describes use in domestic and international hospitals; official manufacturer contact is available for configuration requests.
product family · checked 2026-09-05
Official Korean manufacturer page reviewed. Its family deployment narrative does not specify the K241922 release or establish current interfaces, security or clinical performance.
Sources & review detailsFDA identity, research record, source ledger, and history
Regulatory identity
FDA record and catalog context
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
This audit distinguishes completed source review from fields that have not yet been researched.
Human reviewedStatus
2026-09-05Last searched
21Fields reviewed
11Source classes checked
3Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads
All three stored titles/dates screened. PMID 33053464 concerns myosin VI and is unrelated. PMIDs 36447413 and 39841643 are relevant cardiac-MR leads, but metadata alone does not establish K241922 version linkage; neither is promoted. Live PMID 36447413 retrieval returned HTTP 429. No stored trials. The current discovery snapshot contains 3 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, fda decision summary, acr ai central product, literature index, trial registry, vendor product page, stored candidate metadata, stored recall candidates, pubmed, clinical trials, openfda device recall
Field review details
Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.
Public pricing: Not verified - checked 2026-09-05 - Exact FDA submission
No exact license amount, unit, term or implementation/support costs were established from the reviewed FDA and manufacturer material.
Pricing model: Not yet reviewed
Setup and integration fees: Not yet reviewed
Recurring fees: Not yet reviewed
Minimum commitment: Not yet reviewed
Contract duration: Not yet reviewed
Renewal terms: Not yet reviewed
Cancellation terms: Not yet reviewed
Support and service terms: Not yet reviewed
Trial or pilot terms: Not yet reviewed
Reimbursement: Not publicly available - checked 2026-10-26 - Exact FDA submission
Bounded web search on 2026-10-26 (query: "Phantomics Myomics reimbursement CPT"; top results reviewed) found no vendor or payer page stating coding, coverage or payment for this product. This records what was found, not that none exists.
Data hosting location: Not yet reviewed
Data retention: Not yet reviewed
Documented data use: Not yet reviewed
Hardware requirements: Not yet reviewed
Network requirements: Not yet reviewed
Identity and access: Not yet reviewed
Security: Not verified - checked 2026-09-05 - Exact FDA submission
Current data flow, access controls, retention, hosting and dated scoped security evidence remain unestablished.
Installation timeline: Not yet reviewed
Training: Not verified - checked 2026-09-05 - Exact FDA submission
The FDA specifies experienced cardiovascular-MR users, but vendor onboarding, competency and support commitments are not established.
Monitoring: Not verified - checked 2026-09-05 - Exact FDA submission
Editorial acceptance question: assess each supported MR sequence, manual corrections and failed segmentations locally; no vendor monitoring capability is verified.
Sonic DL is deep-learning MRI reconstruction for highly undersampled or accelerated cardiac acquisitions on compatible GE 1.5T and 3.0T MRI systems for pediatric and adult patients.
Accessory acquisition, reconstruction, and display of cardiovascular MR images on compatible 1.5T and 3T whole-body MRI systems for trained-physician interpretation.
Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.
Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.
Accepted repository change history
No entry has been added to this scoped change history for this record. This is not proof that the record never changed.